17

General Information


DRACP ID  DRACP04816

Peptide Name   17

Sequence  YXGFM

Sequence Length  5

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  X=Cα -dialkylated glycine (Aaa2,2 )

Chiral  L



Physicochemical Information


Formula  C25H30N4O5S

Absent amino acids  ACDEHIKLNPQRSTVW

Common amino acids  FGMYX

Mass  68012

Pl  6.09

Basic residues  0

Acidic residues  0

Hydrophobic residues  1

Net charge  0

Boman Index  613

Hydrophobicity  60

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  372.5

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 16722632

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




CancerPPD ID  3966

CancerPPD ID  3967

CancerPPD ID  3968

CancerPPD ID  3969

CancerPPD ID  3970

CancerPPD ID  3971

CancerPPD ID  3972

CancerPPD ID  3973

CancerPPD ID  3974

CancerPPD ID  3975

CancerPPD ID  3976

CancerPPD ID  3977

CancerPPD ID  3978

CancerPPD ID  3979

CancerPPD ID  3980

CancerPPD ID  3981

CancerPPD ID  3982

CancerPPD ID  3983

CancerPPD ID  3984

CancerPPD ID  3985

CancerPPD ID  3986

CancerPPD ID  3987

CancerPPD ID  3988

CancerPPD ID  3989

CancerPPD ID  3990

CancerPPD ID  3991

CancerPPD ID  3992

CancerPPD ID  3993

CancerPPD ID  3994

DRACP is developed by Dr.Zheng's team.